CellWell record HH-132113
Prediagnostic serum iodine and selenium in relation to breast cancer survival
Magdalena Szramka; Malte Sandsveden; Kamil Demircan; Signe Borgquist; Ann Rosendahl; Jonas Manjer
2026
In plain language
Among 918 women with breast cancer, high prediagnostic serum iodine combined with high serum selenium was associated with significantly higher breast cancer-specific and overall mortality, while selenium alone predicted lower mortality.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-132113
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.